June 1, 2018
The New York Post added its voice of support to President Donald Trump’s decision this week to sign Right to Try into law, protecting terminally ill patients’ right to try medicines that have not yet been approved by the federal government for market.
In a Post editorial titled “Right to Try Act: A bipartisan win for a basic freedom,” the nation’s fourth-largest newspaper expressed its strong support for the law, writing:
When you’re headed to death without a miracle, you have every right to try an experimental treatment. We’re glad to see Congress recognize that fact by passing the Right to Try Act…
Why stand in the way of letting someone who’s dying take a risk? As Trump said, it’s a “fundamental freedom.”
That’s why 40 states have already passed Right to Try laws — and why Democratic Sens. Joe Manchin (W. Va.) and Joe Donnelly (Ind.) co-sponsored it with Republican Sen. Ron Johnson (Wis.).
If the new law “saves one person, it’s worth it,” said Christina Sandefur of the Goldwater Institute, a prime force in pushing the reform. And it clearly gives thousands more terminally ill people “a last chance — and the right to hope.”
You can read the full editorial here.